Found: 8
Select item for more details and to access through your institution.
2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S84, doi. 10.1093/ofid/ofz359.183
- By:
- Publication type:
- Article
Reply to Farkouh RA et al. Comment on 'Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children'.
- Published in:
- Infectious Diseases & Therapy, 2015, v. 4, n. 2, p. 235, doi. 10.1007/s40121-015-0062-1
- By:
- Publication type:
- Article
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children.
- Published in:
- Infectious Diseases & Therapy, 2015, v. 4, n. 1, p. 93, doi. 10.1007/s40121-014-0053-7
- By:
- Publication type:
- Article
Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 35, doi. 10.1007/s00262-006-0168-0
- By:
- Publication type:
- Article
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.
- Published in:
- Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 1/2, p. 426, doi. 10.1111/j.1582-4934.2008.00650.x
- By:
- Publication type:
- Article
N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation.
- Published in:
- Journal of Applied Polymer Science, 2008, v. 109, n. 5, p. 3050, doi. 10.1002/app.28466
- By:
- Publication type:
- Article
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Preclinical Evaluation of Linear HPMA-Doxorubicin Conjugates with pH-Sensitive Drug Release: Efficacy, Safety, and Immunomodulating Activity in Murine Model.
- Published in:
- Pharmaceutical Research, 2010, v. 27, n. 1, p. 1, doi. 10.1007/s11095-009-9999-7
- By:
- Publication type:
- Article